|
Title
|
Publication Date
|
Price
|
Relevance
|
|
Prostate Cancer Drug Pipeline Update 2011
|
Feb 2011 |
£1,245 |
100% |
|
Triple Analysis: Leukemia, Melanoma and Prostate Cancer
|
Nov 2010 |
£2,865 |
99% |
|
Triple Analysis: Lymphoma, Melanoma and Prostate Cancer
|
May 2011 |
£2,865 |
99% |
|
Triple Analysis: Leukemia, Melanoma and Prostate Cancer
|
Apr 2011 |
£2,865 |
99% |
|
Triple Analysis: Leukemia, Lymphoma and Prostate Cancer
|
May 2011 |
£2,865 |
99% |
|
Triple Analysis: Breast Cancer, Melanoma and Prostate Cancer
|
Nov 2010 |
£2,865 |
99% |
|
Triple Analysis: Lymphoma, Pancreatic Cancer and Prostate Cancer
|
May 2011 |
£2,865 |
99% |
|
Triple Analysis: Breast Cancer, Lymphoma and Prostate Cancer
|
May 2011 |
£2,865 |
99% |
|
Triple Analysis: Breast Cancer, Leukemia and Prostate Cancer
|
Apr 2011 |
£2,865 |
99% |
|
Triple Analysis: Melanoma, Prostate Cancer and Angiogenesis
|
Jan 2012 |
£2,865 |
99% |
|
Triple Analysis: Melanoma, Prostate Cancer and Peptides
|
Nov 2011 |
£2,865 |
99% |
|
Triple Analysis: Lung Cancer, Melanoma and Prostate Cancer
|
Jul 2011 |
£2,865 |
99% |
|
Triple Analysis: Lymphoma, Prostate Cancer and Angiogenesis
|
Jan 2012 |
£2,865 |
99% |
|
Triple Analysis: Leukemia, Prostate Cancer and Angiogenesis
|
Jan 2012 |
£2,865 |
99% |
|
Triple Analysis: Lymphoma, Prostate Cancer and Peptides
|
Nov 2011 |
£2,865 |
99% |
|
Triple Analysis: Leukemia, Prostate Cancer and Peptides
|
Nov 2011 |
£2,865 |
99% |
|
Triple Analysis: Leukemia, Lymphoma and Prostate Cancer
|
Apr 2011 |
£2,865 |
99% |
|
Triple Analysis: Lung Cancer, Lymphoma and Prostate Cancer
|
Jul 2011 |
£2,865 |
99% |
|
Triple Analysis: Pancreatic Cancer, Prostate Cancer and Angiogenesis
|
Jan 2012 |
£2,865 |
99% |
|
Triple Analysis: Breast Cancer, Prostate Cancer and Angiogenesis
|
Jan 2012 |
£2,865 |
99% |
|
Triple Analysis: Leukemia, Lung Cancer and Prostate Cancer
|
Jul 2011 |
£2,865 |
99% |
|
Triple Analysis: Melanoma, Prostate Cancer and Apoptosis
|
Dec 2011 |
£2,865 |
99% |
|
Triple Analysis: Pancreatic Cancer, Prostate Cancer and Peptides
|
Nov 2011 |
£2,865 |
99% |
|
Triple Analysis: Breast Cancer, Prostate Cancer and Peptides
|
Nov 2011 |
£2,865 |
99% |
|
Triple Analysis: Lymphoma, Prostate Cancer and Cancer Vaccines
|
May 2011 |
£2,865 |
99% |
|
Triple Analysis: Lymphoma, Prostate Cancer and Apoptosis
|
Dec 2011 |
£2,865 |
99% |
|
Triple Analysis: Colorectal Cancer, Lymphoma and Prostate Cancer
|
May 2011 |
£2,865 |
99% |
|
Triple Analysis: Leukemia, Prostate Cancer and Cancer Vaccines
|
Apr 2011 |
£2,865 |
99% |
|
Triple Analysis: Leukemia, Prostate Cancer and Apoptosis
|
Dec 2011 |
£2,865 |
99% |
|
Triple Analysis: Colorectal Cancer, Leukemia and Prostate Cancer
|
Apr 2011 |
£2,865 |
99% |